Innovent Bio pockets HK$2.4bn from top-up
Chinese biotechnology firm Innovent Biologics has raised HK$2.39bn ($304.3m) after selling a chunk of stock through a top-up placement.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: